Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2
Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 have?
Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 has 2 citations in the OpenAlex counts ScholarIQ stores.
When was Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 published?
Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 has 2021 year in the ScholarIQ index.
What is the open-access status of Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2?
Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 has bronze oa status in the ScholarIQ index.
What is the DOI of Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2?
The DOI for Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 is on the source record.
What is the PMID of Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2?
The PMID for Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 is on the source record.
What is the OpenAlex record for Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2?
The OpenAlex for Plasmapheresis: a feasible choice for bullous pemphigoid patients infected with SARS‐CoV‐2 is on the source record.